Format

Send to

Choose Destination
Lancet Respir Med. 2017 Apr;5(4):247-248. doi: 10.1016/S2213-2600(17)30091-7.

Clinical trial research in focus: overcoming barriers in MDR-TB clinical trials.

Author information

1
Division of Infection and Immunity, University College London and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, UK.
2
Institute for Global Health, University College London, London, UK. Electronic address: i.abubakar@ucl.ac.uk.
PMID:
28353422
DOI:
10.1016/S2213-2600(17)30091-7
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center